GIM
APLS

Granahan Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Granahan Investment Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-175,696
Closed -$3.84M – 155
2025
Q1 		$3.84M Buy
175,696
+21,278
+14% +$588K 0.19% 111
2024
Q4 		$4.93M Buy
154,418
+3,840
+3% +$115K 0.21% 108
2024
Q3 		$4.34M Buy
150,578
+28,195
+23% +$1.04M 0.17% 138
2024
Q2 		$4.69M Buy
122,383
+55,786
+84% +$2.53M 0.19% 130
2024
Q1 		$3.91M Buy
66,597
+24,356
+58% +$1.55M 0.14% 138
2023
Q4 		$2.53M Sell
42,241
-33,879
-45% -$1.72M 0.08% 154
2023
Q3 		$2.9M Sell
76,120
-37,655
-33% -$1.65M 0.1% 149
2023
Q2 		$10.4M Sell
113,775
-49,676
-30% -$4.29M 0.32% 87
2023
Q1 		$10.8M Sell
163,451
-19,057
-10% -$1.1M 0.33% 85
2022
Q4 		$9.44M Buy
182,508
+45,773
+33% +$2.43M 0.29% 94
2022
Q3 		$9.34M Sell
136,735
-4,857
-3% -$287K 0.3% 90
2022
Q2 		$6.4M Sell
141,592
-12,331
-8% -$562K 0.22% 103
2022
Q1 		$7.82M Buy
153,923
+70,322
+84% +$3.1M 0.19% 107
2021
Q4 		$3.95M Buy
+83,601
New +$3.29M 0.08% 161

Other funds holding APLS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Granahan Investment Management's APLS Position: Q2 2025 in Review

Granahan Investment Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2025, closing a stake of 175,696 shares — an estimated $3.84M sold.

Granahan Investment Management first reported a position in APLS in Q4 2021 and held it in 14 quarters. The position peaked at $10.8M in Q1 2023. 247 funds tracked by Wall St. Rank hold APLS as of Q2 2025.

  • Granahan Investment Management reported no remaining Apellis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Granahan Investment Management sold 175,696 Apellis Pharmaceuticals shares in Q2 2025, an estimated $3.84M.
  • Granahan Investment Management first reported a position in Apellis Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Granahan Investment Management's Apellis Pharmaceuticals position peaked at $10.8M in Q1 2023.
  • 247 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2025.

Based on Granahan Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.